Robots Making Precision Medicines

Our robots help the life science industry make precision medicines for all patients.

We believe in a world where every patient has access to next-gen, precision medicines.
Multiply Labs’ robotic technology is the gold standard for the manufacturing of these life-saving products.

ROBOTIC-ARM-3-1
fred-parietti-zoom-darker

Fred Parietti, Ph.D.

Co-Founder & CEO

Fred holds a PhD in robotics from MIT and has extensive experience in the design of autonomous robotic systems (awarded with the MIT Mechanical Engineering De Florez Design Award). Before MIT, Fred worked on advanced robotics at Carnegie Mellon University, the Polytechnic University of Milan (Italy) and ETH Zurich (Switzerland). Fred has authored or co-authored 16 peer-reviewed scientific publications, which have been cited more than 1,500 times. He is also a co-inventor in 10 patents and patent applications.

fred side 1
fred side 2
fred side 3a
fred side 4

Jason Arcediano

Chief Business Officer

Jason spent over 30 years in Biotechnology and has played a critical role in the innovation and expansion of cell and gene therapy. Previously, Jason held various senior leadership roles in business development, operations, M&A, Strategic Alliances, and capital project management at Becton Dickinson, Miltenyi Biotec, Rentschler Bio, Lonza Biologics, and most recently as SVP at AGC Bio.

Untitled-4
Untitled-5
Untitled-6
Untitled-12
Jason-big v3

Management
Umberto Scarfogliero

Umberto Scarfogliero

VP of Robotics R&D
Marae Hartwell

Marae Hartwell

Head of Operations
Jeff Curhan

Jeff Curhan

VP of Robotics Product Engineering
Alice Melocchi

Alice Melocchi

Co-Founder & CSO

Advisors
Mike Doherty

Mike Doherty

Advisor

Board Member, Advisor and Investor for biotech startups.
Formerly: SVP, Foundation Medicine; and SVP, Regulatory Affairs, Roche.

Joe Betts-Lacroix

Joe Betts-Lacroix

Advisor

Retro Biosciences, CEO
Executive Director
HEALTH EXTENSION FOUNDATION
Biotech startups’ Advisory Board Member

Bo Zhou, MSc, PhD

Bo Zhou, MSc, PhD

Advisor Pharmaceutical Development Strategies

Head of Pharmaceutical Product Development and Manufacturing, Senior Director, Neumora.

Formerly: Head of Pharmaceutical Product Development and Manufacturing at Zogenix, Inc. (acquired by UCB).

Thomas Gaziano, MD, MSc

Thomas Gaziano, MD, MSc

Medical Advisor

Physician, Director of Health Economics and Outcomes-Cardiovascular Innovations Brigham and Women’s Hospital, Harvard Medical School

Vincent Chan

Vincent Chan

Scientific Advisor

Assistant Professor at UCSF, Chief Strategy Officer of ImmunoX,
Director of the Office for Collaborative Research

Scott Dylla, PhD

Scott Dylla, PhD

Advisor

Biotech Independent Investor & Advisor

Throop Wilder

Throop Wilder

Advisor

Quadratic 3D, President and CEO
24M Technologies, Executive Chairman

Carlos Parra

Carlos Parra

Quality Advisor

Quality and GxP Consultant
Former VP Quality and Regulatory Compliance at Alexza, Theravance and Telik

Enrico Ferro, MD.

Enrico Ferro, MD.

Medical Advisor

Cardiologist & Clinical Researcher, Harvard Medical School

Leandro Agro

Leandro Agro

Senior Design Advisor

Exponential Technologies Director,
NTT Disruption
+20y IxD/UX Guru / IoT pioneer / Patent contributor / book author

casdin-gray
founders-fund-gray
lux-gray
y-50-gray
goat-capital-gray
garage-capital-gray

Investors

$20 Million Series A is led by Casdin Capital, with participation from Lux Capital and Pathfinder, Founders Fund’s early stage investment vehicle to support the deployment of cloud-controlled robotic systems to enable drug production at industrial scale.

BusinessWire